Drug information for AGGRASTAT
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
EQ 12.5MG BASE/50ML (EQ 0.25MG BASE/ML)
Discontinued
TIROFIBAN HYDROCHLORIDE
tirofiban
MEDICURE
20912
2004-05-26 Letter
2004-05-26 Review
2004-05-26 Review
2003-03-10 Letter
2002-07-24 Letter
2001-09-25 Letter
2001-03-23 Letter
1999-07-09 Letter
1999-07-09 Label
1998-05-14 Letter
1998-05-14 Label
INJECTABLE; INJECTION
EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML)
Prescription
(Reference Drug)
TIROFIBAN HYDROCHLORIDE
tirofiban
MEDICURE
20913
2010-06-04 Review
2004-05-26 Review
2004-05-26 Review
2003-07-24 Letter
2002-07-24 Letter
2002-05-17 Letter
2001-09-25 Letter
2001-03-23 Letter
1999-07-09 Letter
1999-07-09 Label
1998-05-14 Letter
1998-05-14 Label
INJECTABLE; INJECTION
EQ 25MG BASE/500ML (EQ 0.05MG BASE/ML)
Discontinued
TIROFIBAN HYDROCHLORIDE
tirofiban
MEDICURE
"
INJECTABLE; INJECTION
EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)
Prescription
TIROFIBAN HYDROCHLORIDE
tirofiban
MEDICURE
"
Drug Adverse Effects information for AGGRASTAT
Role code
Indications
Reaction
# Reports
PS
ACUTE MYOCARDIAL INFARCTION
CEREBRAL HAEMORRHAGE
1
C
ANGINA UNSTABLE
PROCEDURAL COMPLICATION
3
C
ANGINA UNSTABLE
PULMONARY HAEMORRHAGE
3
C
CORONARY ARTERY DISEASE
PROCEDURAL COMPLICATION
1
C
CORONARY ARTERY DISEASE
PULMONARY HAEMORRHAGE
1
Ads by Google